Does BROLUCIZUMAB Cause Retinal vascular occlusion? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Retinal vascular occlusion have been filed in association with BROLUCIZUMAB (BEOVU). This represents 1.2% of all adverse event reports for BROLUCIZUMAB.
8
Reports of Retinal vascular occlusion with BROLUCIZUMAB
1.2%
of all BROLUCIZUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Retinal vascular occlusion From BROLUCIZUMAB?
Of the 8 reports, 1 (12.5%) required hospitalization.
Is Retinal vascular occlusion Listed in the Official Label?
Yes, Retinal vascular occlusion is listed as a known adverse reaction in the official FDA drug label for BROLUCIZUMAB.
What Other Side Effects Does BROLUCIZUMAB Cause?
Visual impairment (116)
Vision blurred (106)
Eye pain (81)
Vitreous floaters (74)
Vitritis (65)
Ocular hyperaemia (62)
Off label use (62)
Subretinal fluid (62)
Retinal vasculitis (52)
Eye inflammation (50)
What Other Drugs Cause Retinal vascular occlusion?
BROLUCIZUMAB-DBLL (112)
VANCOMYCIN (69)
AFLIBERCEPT (36)
ADALIMUMAB (35)
SILDENAFIL (18)
IBRUTINIB (17)
BEVACIZUMAB (16)
RANIBIZUMAB (14)
LENALIDOMIDE (13)
APIXABAN (11)
Which BROLUCIZUMAB Alternatives Have Lower Retinal vascular occlusion Risk?
BROLUCIZUMAB vs BROLUCIZUMAB-DBLL
BROLUCIZUMAB vs BROMAZEPAM
BROLUCIZUMAB vs BROMFENAC
BROLUCIZUMAB vs BROMHEXINE
BROLUCIZUMAB vs BROMOCRIPTINE